NYSEARCA:FBT First Trust NYSE Arca Biotechnology Index Fund (FBT) Price, Holdings, & News → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free FBT Stock Alerts $146.26 +3.33 (+2.33%) (As of 02:26 PM ET) Add Compare Share Share Today's Range$143.82▼$146.5950-Day Range$141.52▼$155.9952-Week Range$130.27▼$161.41Volume14,171 shsAverage Volume28,580 shsMarket Capitalization$1.11 billionAssets Under Management$1.09 billionDividend Yield0.00%Net Expense Ratio0.55% Stock AnalysisStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings Get First Trust NYSE Arca Biotechnology Index Fund alerts: Email Address About First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT)The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.Read More FBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBT ETF News HeadlinesMarch 31, 2024 | finance.yahoo.comFirst Trust NYSE Arca Biotechnology Index Fund (FBT)January 6, 2024 | theglobeandmail.comClosing Bell: First Trust NYSE Arca Biotechnology ETF up on Friday (FBT)April 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.January 6, 2024 | theglobeandmail.comClosing Bell: First Trust NYSE Arca Biotechnology ETF flat on Friday (FBT)October 23, 2023 | benzinga.comFirst Trust Dynamic Europe Equity Income Fund Declares its Monthly Common Share Distribution of $0.07 Per Share for NovemberSeptember 29, 2023 | wsj.comNYSE Arca Major Market IndexApril 27, 2023 | seekingalpha.comFBT First Trust NYSE Arca Biotechnology Index Fund ETFMarch 17, 2023 | wsj.comNYSE Arca Securities Broker/Dealer IndexApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.March 11, 2023 | wsj.comNYSE Arca Gold BUGS IndexSee More Headlines Receive FBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFirst Trust Fund NameFirst Trust NYSE Arca Biotechnology Index Fund Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:FBT Inception Date6/19/2006 Fund ManagerDaniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNYSE Arca Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings31 Fund Statistics Assets Under Management$1.08 billion Average Daily Volume$24,390.20 Discount/Premium-0.08% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorFirst Trust Advisors L.P. CustodianThe Bank of New York Mellon Corporation DistributorFirst Trust Portfolios L.P. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableOptionable Options Volume3 Put Options3 Call Options3 Miscellaneous Outstanding Shares7,600,000Beta0.85 Creation Unit50,000 Creation Fee$500.00 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> First Trust NYSE Arca Biotechnology Index Fund ExpensesTypeFBTHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.40%0.56%0.54%0.50%0.51%Other Expenses0.15%0.40%0.54%0.64%0.58%Total Expense0.55%0.72%0.70%0.74%0.70%Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%Net Expense0.55%0.60%0.60%0.57%0.58% First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings & ExposureTop 10 FBT HoldingsNatera(NASDAQ:NTRA)Holding Weight: 5.14%Bruker(NASDAQ:BRKR)Holding Weight: 3.96%Halozyme Therapeutics(NASDAQ:HALO)Holding Weight: 3.94%Intra-Cellular Therapies(NASDAQ:ITCI)Holding Weight: 3.89%United Therapeutics(NASDAQ:UTHR)Holding Weight: 3.88%Mettler-Toledo International(NYSE:MTD)Holding Weight: 3.62%Neurocrine Biosciences(NASDAQ:NBIX)Holding Weight: 3.60%Exelixis(NASDAQ:EXEL)Holding Weight: 3.56%Corcept Therapeutics(NASDAQ:CORT)Holding Weight: 3.51%BioMarin Pharmaceutical(NASDAQ:BMRN)Holding Weight: 3.46%FBT Sector ExposureFBT Industry ExposureFull Holdings Details Similar ETFsInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RYHFirst Trust Health Care AlphaDEX FundNYSEARCA:FXHInvesco S&P 500 Equal Weight Health Care ETFNYSEARCA:RSPHDirexion Daily S&P Biotech Bull 3x SharesNYSEARCA:LABUiShares U.S. Healthcare Providers ETFNYSEARCA:IHFInstitutional OwnershipRaymond James Financial Services Advisors Inc.Sold 80,762 shares on 4/23/2024Ownership: 1.570%Stablepoint Partners LLCBought 588 shares on 4/23/2024Ownership: 0.028%Raymond James & AssociatesSold 13,879 shares on 4/22/2024Ownership: 1.463%American Financial Advisors LLCSold 168 shares on 4/22/2024Ownership: 0.029%Lake Street Private Wealth LLCBought 330 shares on 4/19/2024Ownership: 0.047%View All Institutional Transactions FBT ETF - Frequently Asked Questions How have FBT shares performed in 2024? First Trust NYSE Arca Biotechnology Index Fund's stock was trading at $158.06 at the start of the year. Since then, FBT stock has decreased by 7.6% and is now trading at $145.99. View the best growth stocks for 2024 here. What does FBT invest in? First Trust NYSE Arca Biotechnology Index Fund is a equity fund issued by First Trust. FBT focuses on health care investments and follows the NYSE Arca Biotechnology Index. The fund's investments total to approximately $1.09 billion assets under management. What stocks does First Trust NYSE Arca Biotechnology Index Fund hold? FBT invests in 31 holdings. Some of the stocks in their portfolio include Natera (NTRA), Bruker (BRKR), Halozyme Therapeutics (HALO), Intra-Cellular Therapies (ITCI), United Therapeutics (UTHR), Mettler-Toledo International (MTD), Neurocrine Biosciences (NBIX), Exelixis (EXEL), Corcept Therapeutics (CORT) and BioMarin Pharmaceutical (BMRN). What is the management fee for First Trust NYSE Arca Biotechnology Index Fund? First Trust NYSE Arca Biotechnology Index Fund's management fee is 0.40% and has other expenses of 0.15%. The net expense ratio for FBT is 0.55%. What other stocks do shareholders of First Trust NYSE Arca Biotechnology Index Fund own? Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust NYSE Arca Biotechnology Index Fund investors own include Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Walt Disney (DIS), Annaly Capital Management (NLY), ONEOK (OKE), Valero Energy (VLO), AbbVie (ABBV), Broadcom (AVGO) and Bristol-Myers Squibb (BMY). Who are First Trust NYSE Arca Biotechnology Index Fund's major shareholders? First Trust NYSE Arca Biotechnology Index Fund's stock is owned by a number of retail and institutional investors. Top institutional investors include Raymond James Financial Services Advisors Inc. (1.57%), Raymond James & Associates (1.46%), Quad Cities Investment Group LLC (0.11%), Juncture Wealth Strategies LLC (0.11%), SignalPoint Asset Management LLC (0.07%) and GoalVest Advisory LLC (0.06%). How do I buy shares of First Trust NYSE Arca Biotechnology Index Fund? Shares of FBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSEARCA:FBT) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust NYSE Arca Biotechnology Index Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
